TrialJAMA oncology2018

Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.

Josef J Fox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.